FINWIRES · TerminalLIVE
FINWIRES

Apeloa Pharmaceutical Gets US FDA Nod for Hypertension, Angina Treatment

By

The U.S. Food and Drug Administration approved Apeloa Pharmaceutical's (SHE:000739) metoprolol succinate extended-release tablets, according to a Friday disclosure to the Shenzhen bourse.

The drug is indicated for hypertension and angina pectoris or chest pain, as well as symptomatic stable chronic heart failure with dysfunction in the left ventricle, among others.

Related Articles